ConMed Buys SurgiQuest For $265m To Help Revive Surgery Products Business
This article was originally published in Clinica
ConMed expects SurgiQuest’s AirSeal laproscopic access management technology will help turnaround its flagging Advanced Surgery device business once it closes the acquisition of SurgiQuest in early 2016.
You may also be interested in...
Medtronic says that most of the clinical trials it is sponsoring are paused due to the pandemic, which means the completion of its PMA application for the Symplicity Spyral renal denervation system will be delayed.
Three-month results of the SPYRAL HTN-OFF MED pivotal trial show renal denervation with Medtronic’s Symplicity Spyral system significantly reduced blood pressure in hypertensive patients not taking anti-hypertensive medications.
Butterfly Network is disseminating the lessons from China and Italy about the poential value of lung ultrasound in the management of COVID-19 patients with respiratory disease.